Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Redmile Group

Redmile Group

Private equity with venture activity · probableSan Francisco, CAredmilegrp.comSEC registered investment adviser

registered adviser; venture funds are 29% of 20 private funds

Importance
41
elevated
Active deployment
8
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
Headquarters
Larkspur, CAadviserinfo.sec.gov
Office address
900 LARKSPUR LANDING CIRCLE, SUITE 270, Larkspur, CA, 94939adviserinfo.sec.gov
Business phone
415-489-9980adviserinfo.sec.gov
Website
HTTP://WWW.REDMILEGROUP.COM
SEC adviser type
registered investment adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Aug 28, 2026
Private funds reported
20 (7 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$4.6Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Regulatory AUM
$4.7Bthe adviser's RAUM, a regulatory measure, never a fund size
Employees
30
business phone
415-489-9980adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 50%series b 50%
Stage at first entry
series a 50%series b 50%
Sectors
Biotechnology 100%
lead rate 0%follow-on rate 0%new logos, 12 months 2
Funds and vehicles
8 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Redmile Growth Investments I, L.P.Growth fund2021 form d first saleMature$157M
Jul 3, 2024
3$122MJul 28, 2022
Redmile Biopharma Investments III, LPFund · ADV: Private Equity Fund2020 form d first saleMature$1.2B
Jul 3, 2024
330$500MJan 4, 2021
Redmile Biopharma Investments II, L.P.Fund2019 form d first saleMature$828M
Jul 3, 2024
138$675M
of $675M
Mar 5, 2020
RAF, L.P.Fund2018 adv first reportedHarvest$261M
Jul 3, 2024
2unknownunknown
Redmile Biotechnologies Investments I Af, L.P.Fund2015 form d first saleHarvest$143M
Jul 3, 2024
80$218M
of $218M
Jul 27, 2018
Redmile Private Investments II, L.P.Fund2015 form d first saleHarvest$61.6M
Jul 3, 2024
29$131M
of $131M
Dec 29, 2017
Redmile Private Investments I Affiliates, LPFeeder or parallel2014 form d first saleHarvest$11.9M
Jul 3, 2024
17$28.7M
of $28.7M
Mar 2, 2017
Redmile Private Investments I, L.P.Fund2013 adv first reportedHarvest$15.9M
Jul 3, 2024
11$0
of $150M
May 20, 2013
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
8 current, 4 departed
Jeremy Charles Green
Managing Member · since Mar 1, 2007
Managing partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Amrit Nmn Nagpal
Managing Director · since Jan 1, 2019
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Michael Stewart Lee
Managing Director · since Jan 1, 2014
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Owen John Leary
Managing Director · since Jan 1, 2019
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Robert Carrington Faulkner
Managing Director · since Jan 1, 2014
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Bryan Ranney Crapo
Chief Operating Officer · since Jan 1, 2014
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Jennifer Kate Ciresi
General Counsel And Chief Compliance Officer · since Mar 1, 2022
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Josh Garcia
Chief Financial Officer · since Jan 1, 2014
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
4 departed (kept with end dates)
Investments on record
2 edges, 2 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Ambrosia Biosciences Inc.Series B · Series Bparticipantunknown$100MunknownMar 31, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Bambusa Therapeutics, Inc.Series A-2 · Series AparticipantunknownunknownunknownNov 17, 2025Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
9 relationships from shared deals, counted for the whole firm
Blue Owl Healthcare Opportunities 1 shared · one timeBVF Partners 1 shared · one timeSamsara Biocapital, LLC 1 shared · one timeBoulder Ventures 1 shared · one timeDeep Track Capital 1 shared · one timeInce Capital Ltd. 1 shared · one timeBVF Partners L 1 shared · one timeRA Capital Management, LP 1 shared · one timeATHOS KG 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
22 dated events
  1. Mar 28, 2024
    Christopher Charles Oconnor (Managing Director) no longer on Schedule A of Redmile Group
    Person leftPeopleInferenceChristopher Charles OconnorSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 1, 2022
    Jennifer Kate Ciresi joined Schedule A of Redmile Group as General Counsel And Chief Compliance Officer
    Person joinedPeopleFactJennifer Kate CiresiSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Feb 9, 2022
    Redmile Growth Investments I, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund)
    Fund first reported on Form ADVFundsFactRedmile Growth Investments I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Dec 2, 2021
    Rachel Nmn Chang (Chief Compliance Officer) no longer on Schedule A of Redmile Group
    Person leftPeopleInferenceRachel Nmn ChangSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Feb 26, 2021
    Redmile Biopharma Investments III, LP first reported on Form ADV by Redmile Group (Venture Capital Fund), GAV $553,890,000
    Fund first reported on Form ADVFundsFactRedmile Biopharma Investments III, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Mar 29, 2019
    Redmile Biopharma Investments II, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund)
    Fund first reported on Form ADVFundsFactRedmile Biopharma Investments II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Mar 29, 2019
    Joshua Charles Fisher (Managing Director) no longer on Schedule A of Redmile Group
    Person leftPeopleInferenceJoshua Charles FisherSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Jan 1, 2019
    Amrit Nmn Nagpal joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactAmrit Nmn NagpalSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Jan 1, 2019
    Owen John Leary joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactOwen John LearySEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Mar 1, 2018
    Nitzan Sternberg (Chief Compliance Officer) no longer on Schedule A of Redmile Group
    Person leftPeopleInferenceNitzan SternbergSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Mar 1, 2018
    RAF, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund)
    Fund first reported on Form ADVFundsFactRAF, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Feb 1, 2018
    Rachel Nmn Chang joined Schedule A of Redmile Group as Chief Compliance Officer
    Person joinedPeopleFactRachel Nmn ChangSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  13. Jan 1, 2016
    Nitzan Sternberg joined Schedule A of Redmile Group as Chief Compliance Officer
    Person joinedPeopleFactNitzan SternbergSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  14. Dec 15, 2015
    Redmile Biotechnologies Investments I Af, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund), GAV $30,000,000
    Fund first reported on Form ADVFundsFactRedmile Biotechnologies Investments I Af, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  15. Dec 15, 2015
    Redmile Private Investments II, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund), GAV $65,000,000
    Fund first reported on Form ADVFundsFactRedmile Private Investments II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  16. Jul 1, 2015
    Joshua Charles Fisher joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactJoshua Charles FisherSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  17. Mar 31, 2015
    Redmile Private Investments I Affiliates, LP first reported on Form ADV by Redmile Group (Venture Capital Fund), GAV $28,735,000
    Fund first reported on Form ADVFundsFactRedmile Private Investments I Affiliates, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  18. Jan 1, 2014
    Christopher Charles Oconnor joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactChristopher Charles OconnorSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  19. Jan 1, 2014
    Robert Carrington Faulkner joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactRobert Carrington FaulknerSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  20. Jan 1, 2014
    Michael Stewart Lee joined Schedule A of Redmile Group as Managing Director
    Person joinedPeopleFactMichael Stewart LeeSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  21. Oct 30, 2013
    Redmile Private Investments I, L.P. first reported on Form ADV by Redmile Group (Venture Capital Fund), GAV $35,750,000
    Fund first reported on Form ADVFundsFactRedmile Private Investments I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  22. Mar 30, 2012
    Redmile Group first filed Form ADV (IA)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Private equity with venture activity (probable, 75%, cls-1)
    registered adviser; venture funds are 29% of 20 private funds
  2. Sep 12, 2026
    Private equity with venture activity (probable, 75%, cls-1)
    registered adviser; venture funds are 29% of 18 private funds
Evidence
56 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_funds_reportedAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeregistered_investment_adviserAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeregistered_investment_adviserJul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-30Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-08-28Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-07-03Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusApprovedAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2007-04-19Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds0Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone415-489-9980Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone415-489-9980Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Employees30Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Employees35Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersLarkspur, CAAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersSan Francisco, CAJul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address900 LARKSPUR LANDING CIRCLE, SUITE 270, Larkspur, CA, 94939Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office addressONE LETTERMAN DRIVE, BLDG D, STE D3-300, San Francisco, CA, 94129Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
PE funds reported3Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported20Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported18Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$4.6BAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$7.2BJul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Regulatory AUM (adviser, not fund size)$4.7BAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Regulatory AUM (adviser, not fund size)$6.5BJul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported7Aug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported7Jul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://WWW.REDMILEGROUP.COMAug 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://WWW.REDMILEGRP.COMJul 3, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Website statusunreachable
“home page did not answer with HTML”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Website statusunreachable
“home page did not answer with HTML”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)